文献速递炎症性肠病

随机临床试验:全肠内营养对比标准治疗用于急性重度溃疡性结肠炎

Randomised clinical trial: exclusive enteral nutrition versus standard of care for acute severe ulcerative colitis.
PubMed 文献 · Aliment Pharmacol Ther · 2021-01-13

这项开放标签随机对照试验纳入62例急性重度溃疡性结肠炎(ASUC)患者,比较全肠内营养(EEN)联合静脉糖皮质激素与标准治疗(SOC)的疗效。EEN组激素失败率意向性分析为25%对43%(P=0.051),符合方案分析为19%对43%(P=0.04),结肠切除率无差异,EEN组住院更短、第7天白蛋白更高、炎症指标下降更多、6个月结肠切除/住院复合结局更低。

要点

  • EEN联合激素可能提高ASUC患者激素应答,符合方案分析激素失败率19%对43%。
  • EEN组住院中位10天短于SOC组13天,第7天白蛋白34±4 vs 29±3 g/L。
  • 结肠切除率两组无差异(9% vs 13%),6个月复合结局EEN组更低(16% vs 39%)。

核心结论

  • 7天EEN辅助治疗可能增强ASUC患者对静脉糖皮质激素的应答。

研究设计与样本

  • 开放标签随机对照试验,2018年8月至2020年5月收治的ASUC患者按1:1随机分配至EEN或SOC。
  • 共62例患者(平均年龄35.3±12.1岁,40%男性),EEN组32例,SOC组30例。
  • EEN组接受半要素配方7天并联合SOC;部分患者在第1天和第7天进行16S rRNA测序粪便微生物分析。

主要发现

  • 激素失败率EEN组低于SOC组:意向性分析25% vs 43%(P=0.051),符合方案分析19% vs 43%(P=0.04)。
  • 结肠切除率两组无差异(9% vs 13%;P=0.41)。
  • EEN组住院时间更短[中位10(8-17)vs 13(8-24)天;P=0.04]。
  • EEN组第7天白蛋白更高(34±4 vs 29±3 g/L,P<0.01),血清C反应蛋白和粪便钙卫蛋白下降幅度更大(均P=0.04)。
  • EEN组6个月结肠切除/住院复合结局更低(16% vs 39%;P=0.045),第7天Erysipelotrichaceae丰度增加,Bifidobacterium和Veillonellaceae减少。

临床怎么用

  • 对于ASUC住院患者,可考虑在静脉糖皮质激素基础上加用7天半要素配方EEN,以期提高激素应答并缩短住院。
  • EEN对结肠切除率无显著影响,需结合患者耐受性和营养状态个体化决策。

局限性

  • 开放标签设计可能引入偏倚。
  • 样本量较小(62例),意向性分析激素失败率P=0.051未达统计学显著。
  • 粪便微生物分析仅部分患者完成。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intravenous corticosteroids are the mainstay of therapy for acute severe ulcerative colitis (ASUC), but 30%-40% of patients fail to respond. AIM: To investigate the effectiveness of exclusive enteral nutrition (EEN) as adjunctive therapy to intravenous corticosteroids in patients with ASUC. METHODS: This was an open-label randomised controlled trial, in which patients who were admitted with ASUC between August 2018 and May 2020 were randomised 1:1 to EEN or standard of care (SOC). Patients on EEN received a semi-elemental formula for 7 days along with SOC. The primary outcome was corticosteroid failure, defined by the need for salvage medical therapy or colectomy. Faecal microbial analysis was performed on day 1 and day 7 by 16s ribosomal RNA sequencing in some patients. RESULTS: Of 62 patients (mean age 35.3 ± 12.1 years, 40% male), 32 were randomised to EEN and 30 to SOC. Corticosteroid failure was lower on EEN compared to SOC (intention-to-treat analysis 25% vs 43%, P = 0.051; per protocol analysis 19% vs 43%, P = 0.04), without any difference in colectomy rate (9% vs 13%; P = 0.41). Patients on EEN had a shorter hospital stay [median (range) 10 (8-17) vs 13 (8-24) days; P = 0.04], higher day 7 albumin level (34 ± 4 vs 29 ± 3 g/L, P < 0.01), greater reduction in serum C-reactive protein and faecal calprotectin levels (both P = 0.04) and a lower composite outcome of colectomy/hospitalisation at 6 months (16% vs 39%; P = 0.045) compared to SOC. Patients on EEN showed increased abundance of Erysipelotrichaceae on day 7, with reduced Bifidobacterium and Veillonellaceae compared to SOC. CONCLUSIONS: EEN for 7 days may augment corticosteroid responsiveness in patients with ASUC. (REF/2018/05/019844; CTRI/2020/06/025989).

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Sahu P, Kedia S, Vuyyuru SK, et al. Randomised clinical trial: exclusive enteral nutrition versus standard of care for acute severe ulcerative colitis. Aliment Pharmacol Ther. 2021. PMID: 33440046. doi:10.1111/apt.16249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。